Navigation Links
Protein Research Marketing Insights
Date:9/23/2008

ARLINGTON, Va., Sept. 23 /PRNewswire/ -- BioInformatics, LLC (http://www.gene2drug.com), the leading market research and consulting firm serving the life science industry, announces the publication of its latest report, "Protein Research: Strategies for Marketing to Chemists and Biologists." A joint effort between BioInformatics, LLC and the American Chemical Society, the report is designed to help suppliers of protein research tools and technologies identify workflow patterns and applications, discover unmet technology needs and explore instrument-purchasing drivers among biologists and chemists.

"A more in-depth understanding of the needs of scientists studying protein research is of growing importance as the field becomes more complex and funding sources become harder to obtain," observed Dr. Tamara Zemlo, Director of Syndicated Research and Analysis for BioInformatics, LLC. "Furthermore, we have identified significant overlap in how biologists and chemists use the equipment, thereby allowing companies to streamline the marketing effort to appeal to scientists in both disciplines."

By exploring the usage and purchase drivers behind both the higher dollar mass spectrometry and HPLC instrumentation, and the less expensive electrophoresis equipment products, manufacturers and scientists alike can understand what, in addition to cost, is influencing purchase decisions. This study explores how these preferences play out differently (and the same) between biologists and chemists.

Designed to help identify key areas of investigation among protein researchers, perceived bottlenecks, potential budgetary implications and customer perceptions of leading providers of instrumentation, this benchmarking study allows suppliers to gain keen insight into the evolving needs of their protein research customers, while more clearly defining certain industry-wide best practices. The information in this report can be used to provide direction as to how suppliers can increase sales volume through innovative product offerings and continue to better meet the needs of current users.

"One of the greatest areas of concern is an ability to meet the higher demand for increased throughput," Zemlo noted. Contained within the report are "Scorecards" for each of the instruments studied. These scorecards provide at-a-glance information as to how biologists and chemists use their protein research tools, what features are most important to them and what kind of purchase criteria they use for choosing vendors.

"Protein Research: Strategies for Marketing to Chemists and Biologists" is based on responses to a 53-question online survey conducted by BioInformatics, LLC. 275 chemists and 443 biologists from North America completed an online survey fielded between June 25 and August 1, 2008. Plan to attend a free webinar to discuss this report on Wednesday, October 22 at 1pm EDT. To register for your virtual seat at the webinar, email m.follin@gene2drug.com. For a complimentary Executive Summary of this report, please visit http://www.gene2drug.com/report/197/

ABOUT BIOINFORMATICS, LLC

BioInformatics, LLC is the premier research and advisory firm serving the life science industry. By leveraging our professional social network of more than 38,000 biomedical researchers, we have supported more than 300 companies and provided insights that lead to better business decisions. Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

For more information, please contact:

Mary Follin

Director of Communications

BioInformatics, LLC

2111 Wilson Blvd., Suite 250

Arlington, VA 22201

703.778.3080 x13 (phone)

m.follin@gene2drug.com

http://www.gene2drug.com/


'/>"/>
SOURCE BioInformatics, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
2. China-Biotics, Inc. Launches Shining Probiotics Protein Powder
3. When proteins, antibodies and other biological molecules kiss, a new kind of biosensor can tell
4. When proteins, antibodies and other biological molecules kiss, a new kind of biosensor can tell
5. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
6. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
7. Decision Biomarkers Awarded U.S. Patent for Protein Array Surface Chemistry
8. STALLERGENES and Protein eXpert Enter Into a Partnership for Producing Mites Recombinant Allergens
9. Alfacell Announces ONCONASE(R) Purchase and Supply Agreement with Scientific Protein Laboratories
10. Decision Biomarkers Launches System for Faster, Easier Quantification of Protein Biomarkers
11. Immune system protein starves staph bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... -- Cousins Properties (NYSE: CUZ ) announced today ... signed a 10-year, approximately 125,000 square-foot lease at Corporate Center, ... the Westshore submarket of Tampa, FL. ... Corporate Center for their new location in Tampa ... executive officer of Cousins Properties. "Amgen is a cutting-edge global ...
(Date:3/27/2017)... Infectex Ltd., a Russian portfolio company of Maxwell Biotech Venture Fund (MBVF), ... the standard drug therapy regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). SQ109 is ... ) and the US National Institutes of Health. ... ... ...
(Date:3/27/2017)... , March 27, 2017  Perthera,s Chief Bioinformatics Officer ... Subha Madhavan , Ph.D., will be speaking at ... Panels. On Monday, March 27, 2017, she will be ... More Usable for Research and Care" (from 10:30 a.m. ... 2017, she will be a participant in the "Making ...
(Date:3/27/2017)... ... ... PMG Research is pleased to announce its participation in the 2nd ... Boston on April 3-4, 2017. The CTC conference focuses on how the industry is ... closer to the patient. Clinical Trial Collaborations also will present an inaugural conference on ...
Breaking Biology Technology:
(Date:2/28/2017)... 28, 2017   Acuant , a leading provider ... significant enhancements to new and core technologies building upon ... include mobile and desktop Acuant FRM TM facial ... a real time manual review of identity documents by ... the fastest and most accurate capture software to streamline ...
(Date:2/27/2017)... WASHINGTON , Feb. 27, 2017   Strategic ... fund, today announced it has led a $3.5 million investment ... collaboration platform. Strategic Cyber Ventures is DC based and ... and Hank Thomas . Ron Gula , ... Tech Ventures, also participated in this series A round ...
(Date:2/22/2017)... With the biometrics market to exceed ... technologies that innovative and agile startups must incorporate ... the changing competitive landscape: multifactor authentication (MFA), point-of-sale ... "Companies can no longer afford to cut ... Dimitrios Pavlakis , Industry Analyst at ABI Research. ...
Breaking Biology News(10 mins):